Related Experiment Video
Updated: Nov 26, 2025
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
An update on the management of PONV in a pediatric patient
Warwick Aubrey Ames1, Kelly Machovec1
1Department of Anesthesiology, Duke University Medical Center, 2301 Erwin Rd, Durham, NC, 27710, USA.
Insights
Postoperative nausea and vomiting (PONV) is a common issue. New antiemetic drugs, especially from oncology, offer better prevention and treatment options for pediatric surgical patients.
Area of Science:
- Anesthesiology
- Pharmacology
- Pediatric Surgery
Background:
- Postoperative nausea and vomiting (PONV) significantly impacts patient satisfaction after anesthesia.
- Diagnosing nausea in pediatric patients presents challenges, necessitating proactive antiemetic strategies.
- Risk assessment tools help anesthesiologists tailor prophylactic treatments for high-risk individuals.
Purpose of the Study:
- To explore the potential of novel antiemetic agents for PONV prophylaxis and treatment in pediatric surgical patients.
- To evaluate how new antiemetics can improve the management of PONV beyond the immediate postoperative phase.
Main Methods:
- Review of emerging antiemetic agents, particularly those developed in oncology.
- Analysis of prognostic tools and assessment scores for identifying at-risk pediatric patients.
- Discussion of multi-drug prophylactic strategies for PONV prevention.
Main Results:
- New antiemetic agents show promise for PONV management.
- Several new drugs possess a long duration of action, aiding sustained control.
- Oncology-derived antiemetics may offer effective solutions for pediatric PONV.
Conclusions:
- Novel antiemetics can enhance the prevention and treatment of PONV in pediatric surgical settings.
- The anesthesiologist's ability to manage PONV is improved by these new agents.
- Effective PONV management is crucial for pediatric patient satisfaction and recovery.
Abstract:
Postoperative nausea and vomiting (PONV) is a major cause of patient dissatisfaction following anesthesia. The difficulty in diagnosing nausea in much of the pediatric population has led to an emphasis on anti-emetic prophylaxis for all. Assessment scores and prognostic tools enable the anesthesiologist to identify patients who are at a greater risk and appropriately apply more aggressive prophylactic, multi-drug strategies. New antiemetics emerging from other medical disciplines, particularly oncology, may have potential use in prophylaxis and treatment of nausea and vomiting in the pediatric surgical population. New agents, many of which have a long duration of action, will augment the anesthesiologist's ability to adequately prevent PONV, and to treat persistent nausea and vomiting that extend beyond the immediate post-operative period.
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management